首页> 外文期刊>Journal of Medicinal Chemistry >Acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase
【24h】

Acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase

机译:无环核苷类似物作为恶性疟原虫dUTPase抑制剂

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We report the discovery of novel uracil-based acyclic compounds as inhibitors of deoxyuridine 5 '-triphosphate nucleotidohydrolase (dUTPase), an enzyme involved in nucleotide metabolism that has been identified as a promising target for the development of antimalarial drugs. Compounds were assayed against both P. falciparum dUTPase and intact parasites. A good correlation was observed between enzyme inhibition and cellular assays. Acyclic uracil derivatives were identified that showed greater or similar potency and in general increased selectivity compared to previously reported inhibitors. The most active compound reported here against the P. falciparum enzyme had a K-i of 0.2 mu M. Molecular modeling studies provided a good rationale for the observed activities. Preliminary ADME studies indicated that some of the lead compounds are drug-like molecules. These compounds are useful tools for further investigating P. falciparum dUTPase for the development of much-needed novel antimalarial drugs.
机译:我们报告发现新型基于尿嘧啶的无环化合物作为脱氧尿苷5'-三磷酸核苷酸水解酶(dUTPase)抑制剂的发现,脱氧尿苷5'-三磷酸核苷酸水解酶(dUTPase)参与核苷酸代谢,已被确定为抗疟药发展的有希望的目标。分析了针对恶性疟原虫dUTPase和完整寄生虫的化合物。在酶抑制和细胞测定之间观察到良好的相关性。鉴定出与先前报道的抑制剂相比,无环尿嘧啶衍生物显示出更大或更相似的效力,并且通常选择性提高。此处报道的针对恶性疟原虫酶的活性最高的化合物的K-i为0.2μM。分子模型研究为观察到的活性提供了良好的理论依据。 ADME的初步研究表明,某些先导化合物是类药物分子。这些化合物是进一步研究恶性疟原虫dUTPase以开发急需的新型抗疟药的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号